Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
CMOs showed an increasing reluctance to take on debt in 2022
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
